RxDoctor Payments Data

Linda Woo, MD

Otolaryngology · Chula Vista, CANPI 1467720656

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Stryker at 28.6% of the total. Reporting peaked in 2019 at $473 and has fallen 60.6% since, to $186 in 2025.

$1,471in general payments, 2019–2025

Across 36 payments — averaging $40.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$420
  • Medtronic$381
  • Optinose US, Inc.$157
  • AbbVie$126
  • Intersect ENT, Inc.$117
  • Inspire Medical Systems, Inc.$73
  • plus $197 from 6 others
$251,474in research payments, 2019–2025

Across 4 payments — averaging $62,869 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Hill Dermaceuticals, Inc.$251K

What the payments were for

  • Food & beverage$1,471100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,471 in reported general payments places this provider in the 55th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$174,239
Medicare patients
354
Services billed
1,628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate307$7,723
Ofloxacin92$4,190
Ipratropium Bromide116$3,714
Azelastine Hcl124$2,969
Prednisolone Acetate26$1,616
Clotrimazole22$872
Omeprazole50$805
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav48$397
Mupirocin16$162
Famotidine13$140
Prednisone42$74

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Chula Vista

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →